King's College London

Research portal

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of AMG 747 on Negative Symptoms in Subjects with Schizophrenia.

Project: Research


  • Amgen Inc.

    Collaborative project - lead institution: Unknown

    Value of award to King´s: £117,843

Status: Completed

Date: 21/09/201225/07/2013

Funding type: Clinical Trial CTIMP (non-commercially sponsored)


View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454